June 16, 2025

Early Results for CAR T-Cell Therapy in Relapsed or Refractory AL Amyloidosis

Initial early results show activity with chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed or refractory amyloid light-chain (AL) amyloidosis in the NEXICART-2 trial.

The ASCO Post

June 10, 2025

FDA OCE Announces Project Interface Outreach Initiative

The Oncology Center of Excellence (OCE) at the FDA has launched Project Interface to advance engagement and outreach to patients with cancer, advocacy organizations, and oncology experts. Its mission ...

The ASCO Post

June 05, 2025

Victoria Villaflor, MD joins UCI Health to share key insights from the 2025 ASCO Annual Meeting

Victoria Villaflor, MD, a recent addition to the UCI Health Chao Family Comprehensive Cancer Center faculty, highlights pivotal findings from ASCO 2025.

UCI Health

June 04, 2025

EMR-Integrated Messaging Drastically Increases Cancer-Related Fertility Preservation Referrals

The integration of a

The ASCO Post

September 26, 2023

Catalyzing Change: Young Moroccan Oncologists Spearhead the Fight Against Sarcoma

Discover the latest insights into sarcoma and rare adult solid cancers from the recent ESMO Sarcoma and Rare Cancers Congress, underlining the significance of multidisciplinary approaches and research efforts. Voices from young oncologists shed light on the pressing need for qualified resources. #ESMO2023

The ASCO Post

October 04, 2023

Using Recent Diagnostic Scans May Cut Time to Treatment for Patients Needing Urgent Palliative Radiotherapy

Using previously taken diagnostic CT scans in place of CT simulation scans to plan simple palliative radiation treatments may substantially reduce the time spent waiting for urgent treatment, improvin...

The ASCO Post

March 12, 2025

Moderate-to-Vigorous Physical Activity May Lower Risk of Cardiovascular Disease–Related Mortality in Women With a Cancer History

Taking more daily steps and engaging in moderate-to-vigorous physical activity may both be associated with a reduced risk of cardiovascular disease–related mortality among postmenopausal women with a ...

The ASCO Post

June 05, 2024

Impact of High Blood Insulin Levels on Triple-Negative Breast Cancer Survival in Black Women

High blood insulin levels may contribute to worse outcomes in Black women with triple-negative breast cancer, according to new findings presented at the Endocrine Society’s Annual Meeting & Exposi...

The ASCO Post

June 10, 2024

FDA’s Oncology Center of Excellence Launches Project 5 in 5, a Crowdsourcing Initiative

The Oncology Center of Excellence initiates 'Project 5 in 5,' a crowdsourcing initiative to identify and answer clinically relevant questions using FDA-approved oncology therapies through pragmatic clinical trials over the next 5 years.

The ASCO Post